Skip Navigation

Coronavirus (COVID-19) information for Dana-Farber patients & families Learn more

Executive Council

  • Revolutionary Developments in Women's Cancers

    On Friday, September 25, the Susan F. Smith Center Executive Council held a virtual presentation, Revolutionary Developments in Women's CancersThe event featured a panel of world-renowned experts who reported on the latest developments made at Dana-Farber, including progress on an ovarian cancer vaccine, updates in treatment for patients with HER2+ breast cancer and a targeted therapy trial in endometrial cancer.  Throughout the presentation attendees also heard inspiring stories of hope and strength from patients and their families.

    To view the full program, see below.

  • About the Executive Council

    The Executive Council of the Susan F. Smith Center for Women's Cancers at Dana-Farber is a forum for women business and community leaders who are committed to helping find cures for women's cancers, the Executive Council is dedicated to:

    • Educating women about breast and gynecologic cancers
    • Cultivating advocates for the Susan F. Smith Center
    • Raising funds to support women's cancers research at Dana-Farber

    The Executive Council was developed to help women in the Greater Boston area learn about women's cancers, while supporting research and treatment in the Susan F. Smith Center for Women's Cancers at Dana-Farber.

    Each year, the Executive Council hosts an educational and fundraising event to share progress and raise critical funds in the fight against women's cancers. Since its inception in 2002, the Executive Council has raised more than $18 million to support research into women's cancers and has educated thousands of women about issues in cancer prevention and treatment.

  • SSC Co-Chairs

  • Support the Smith Center Innovation Fund. Give to lifesaving research.

    make a gift
  • Garber_Article

    Learn more about the Executive Council's efforts to eradicate women's cancers despite the challenges posed by Covid-19.